期刊文献+

辛酸癸酸聚乙二醇甘油酯对加替沙星角膜透过性的影响

Effect of Labrasol on the corneal permeability of gatifloxacin in vitro
原文传递
导出
摘要 目的:研究辛酸癸酸聚乙二醇甘油酯(Labrasol)作为渗透促进剂对加替沙星角膜透过性的影响。方法:采用体外扩散实验考察不同浓度Labrasol对加替沙星角膜透过性的影响。结果:Labrasol质量浓度为0.5%使加替沙星的表观渗透系数增加了1.45倍,与对照组比有显著性差异(P<0.05),质量浓度为1%,1.5%,2%,3%使加替沙星的表观渗透系数分别增加了2.68,4.45,3.90和4.64倍,与对照组比都有极显著性差异(P<0.01)。结论:Labrasol能提高加替沙星的角膜透过性。 Objective:To explore the effect of Labrasol as penetration enhancer on an ocular drug delivery system.Methods:The effect of Labrasol on the corneal permeability of gatifloxacin in vitro was investigated in isolated rabbit corneas.Results:Labrasol at 0.5% improved the apparent permeability coefficient of gatifloxacin by 1.45-fold in comparison with control(P〈0.05).Labrasol at 1%,1.5%,2% and 3% showed a significant improvement on the apparent permeability coefficient of gatifloxacin by 2.68-,4.45-,3.90-and 4.64-fold in comparison with control(P〈0.01),respectively.Conclusion:Labrasol can enhance the corneal apparent permeability of gatifloxacin.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第22期2090-2092,2108,共4页 Chinese Journal of New Drugs
关键词 辛酸癸酸聚乙二醇甘油酯 加替沙星 角膜透过性 Labrasol gatifloxacin corneal permeability
  • 相关文献

参考文献11

  • 1朱曼,王睿.第四代氟喹诺酮类抗菌药——加替沙星[J].中国临床药理学与治疗学,2001,6(4):377-381. 被引量:71
  • 2杜煜,郭惠元.广谱、高效、低毒的新喹诺酮类抗菌药加替沙星[J].国外医药(抗生素分册),2001,22(1):34-39. 被引量:112
  • 3祝红达,王振军,高逢喜.加替沙星滴眼液处方筛选及含量测定[J].中国医院药学杂志,2006,26(9):1180-1182. 被引量:3
  • 4KAUR IP,SMITHA R. Penetration enhancers and ocular bioadhesives : two new avenues for ophthalmic drug delivery [ J ]. Drug Devel Ind Pharm ,2002,28 (4) :353 - 369.
  • 5LIN Y,SHEN Q,KATSUMI H,et al. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats[ J ]. Biol Pharm Bull,2007,30 ( 7 ) : 1301 - 1307.
  • 6SATEESH K, RAMESH P. Nanoemulsions as versatile formulations for paclitaxel delivery : peroral and dermal delivery studies in rats [ J ]. J Invest Dermatol,2007,127 ( 1 ) : 154 - 162.
  • 7张欣华,刘志东,张伯礼,舒乐新,高秀梅,柳占彪,张远.Labrasol对兔眼刺激性评价[J].医药导报,2009,28(7):838-840. 被引量:10
  • 8ROJANASAKULY,ROBINSON JR. Transport mechanisms of the cornea: characterization of barrier perrnselectivity [J]. Int J Pharm, 1989,55 (2) :237 - 246.
  • 9SAETTONE MF, CHETONI P, CERBAI R, et al. Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four β-bloekers, and in vitro/in vivo toxic activity [J]. lnt J Pharm,1996,142(1) :103 - 110.
  • 10刘志东,郭宏,宋成君,李杰,潘卫三.加替沙星眼用凝胶剂的HPLC测定[J].中国医药工业杂志,2005,36(9):570-571. 被引量:6

二级参考文献63

  • 1徐红,陆志华,董文玉,吕晓川.羟丙基甲基纤维素眼用粘弹剂的制备和临床应用[J].中国药业,2005,14(3):49-50. 被引量:5
  • 2赵树清,王金生.新型氟喹诺酮抗菌剂——AM—1155[J].中国医药情报,1996,2(4):249-252. 被引量:4
  • 3副岛林造.Gatifloxacin(GFLX)の概要[J].日本化学疗法学会杂志,1999,47(2):1-1.
  • 4YULIAN L,QI S,HIDEMASA K.Effects of labrasol and ot-her pharmaceutical excipients on the intestinal transport and absorption of rhodamine123,a P-Glyco-protein substrate,in rats[J].Biol Pharm Bull,2007,30(7):1301-1307.
  • 5SATEESH K,RAMESH P.Nanoemulsions as versatile for-mulations for paclitaxel delivery:peroral and dermal delivery studies in rats[J].J Invest Dermatol,2007,127(1):154-162.
  • 6PRADIP K G,RITA J M,MANISH L U.Design and dev-elopment of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability[J].AAPS Pharm Sci Tech,2006,7 (3):E1-E3.
  • 7DRAIZE J H,WOODARD G,CALVERY H O.Methods for the study of irritation and toxicity of substances[J].Pharmacol Exp Ther,1944,82:377-390.
  • 8柴孝也.健康成人におけゐgatifloxacinの体内动态に及ほす水酸化ろルミニウム及びシメジンの影响[J].日本化学疗法学会杂志,1999,47(S-2):218.
  • 9柴孝也.健康成人におけゐgatifloxacinの体内动态に及ぼす铁剂の并用,びに绿茶またば牛乳によゐ服药の影响[J].日本化学疗法学会杂志,1999,47(S-2):224.
  • 10(文)藤笃,中山一朗,大道光秀,他.内科领域感染症に对すゐgatifloxacin の前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):260.

共引文献190

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部